These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22578220)

  • 1. Genomic characterisation of acral melanoma cell lines.
    Furney SJ; Turajlic S; Fenwick K; Lambros MB; MacKay A; Ricken G; Mitsopoulos C; Kozarewa I; Hakas J; Zvelebil M; Lord CJ; Ashworth A; Reis-Filho JS; Herlyn M; Murata H; Marais R
    Pigment Cell Melanoma Res; 2012 Jul; 25(4):488-92. PubMed ID: 22578220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis.
    Furney SJ; Turajlic S; Stamp G; Thomas JM; Hayes A; Strauss D; Gavrielides M; Xing W; Gore M; Larkin J; Marais R
    Pigment Cell Melanoma Res; 2014 Sep; 27(5):835-8. PubMed ID: 24913711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling.
    Cifola I; Pietrelli A; Consolandi C; Severgnini M; Mangano E; Russo V; De Bellis G; Battaglia C
    PLoS One; 2013; 8(5):e63597. PubMed ID: 23704925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Genomic Profiling of Acral Melanoma.
    Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
    J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAB2 amplifications refine molecular classification of melanoma.
    Chernoff KA; Bordone L; Horst B; Simon K; Twadell W; Lee K; Cohen JA; Wang S; Silvers DN; Brunner G; Celebi JT
    Clin Cancer Res; 2009 Jul; 15(13):4288-91. PubMed ID: 19509136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.
    Rawson RV; Johansson PA; Hayward NK; Waddell N; Patch AM; Lo S; Pearson JV; Thompson JF; Mann GJ; Scolyer RA; Wilmott JS
    Lab Invest; 2017 Feb; 97(2):130-145. PubMed ID: 28067894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.
    Millán-Esteban D; García-Casado Z; Manrique-Silva E; Virós A; Kumar R; Furney S; López-Guerrero JA; Requena C; Bañuls J; Traves V; Nagore E
    Eur J Dermatol; 2021 Dec; 31(6):830-838. PubMed ID: 33648909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features.
    Moon KR; Choi YD; Kim JM; Jin S; Shin MH; Shim HJ; Lee JB; Yun SJ
    J Invest Dermatol; 2018 Apr; 138(4):933-945. PubMed ID: 29191620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
    Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
    Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic analysis of melanomas arising in acral sites.
    Zaremba A; Murali R; Jansen P; Möller I; Sucker A; Paschen A; Zimmer L; Livingstone E; Brinker TJ; Hadaschik E; Franklin C; Roesch A; Ugurel S; Schadendorf D; Griewank KG; Cosgarea I
    Eur J Cancer; 2019 Sep; 119():66-76. PubMed ID: 31419753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Genomic Profiling Uncovers Therapeutic Targets of Acral Melanoma in Asian Populations.
    Shi Q; Liu L; Chen J; Zhang W; Guo W; Wang X; Wang H; Guo S; Yue Q; Ma J; Liu Y; Zhu G; Zhao T; Zhao J; Liu Y; Gao T; Li C
    Clin Cancer Res; 2022 Jun; 28(12):2690-2703. PubMed ID: 35294533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling.
    Vergara IA; Mintoff CP; Sandhu S; McIntosh L; Young RJ; Wong SQ; Colebatch A; Cameron DL; Kwon JL; Wolfe R; Peng A; Ellul J; Dou X; Fedele C; Boyle S; Arnau GM; Raleigh J; Hatzimihalis A; Szeto P; Mooi J; Widmer DS; Cheng PF; Amann V; Dummer R; Hayward N; Wilmott J; Scolyer RA; Cho RJ; Bowtell D; Thorne H; Alsop K; Cordner S; Woodford N; Leditschke J; O'Brien P; Dawson SJ; McArthur GA; Mann GJ; Levesque MP; Papenfuss AT; Shackleton M
    Nat Commun; 2021 Mar; 12(1):1434. PubMed ID: 33664264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole genome sequencing of matched primary and metastatic acral melanomas.
    Turajlic S; Furney SJ; Lambros MB; Mitsopoulos C; Kozarewa I; Geyer FC; Mackay A; Hakas J; Zvelebil M; Lord CJ; Ashworth A; Thomas M; Stamp G; Larkin J; Reis-Filho JS; Marais R
    Genome Res; 2012 Feb; 22(2):196-207. PubMed ID: 22183965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-genome landscapes of major melanoma subtypes.
    Hayward NK; Wilmott JS; Waddell N; Johansson PA; Field MA; Nones K; Patch AM; Kakavand H; Alexandrov LB; Burke H; Jakrot V; Kazakoff S; Holmes O; Leonard C; Sabarinathan R; Mularoni L; Wood S; Xu Q; Waddell N; Tembe V; Pupo GM; De Paoli-Iseppi R; Vilain RE; Shang P; Lau LMS; Dagg RA; Schramm SJ; Pritchard A; Dutton-Regester K; Newell F; Fitzgerald A; Shang CA; Grimmond SM; Pickett HA; Yang JY; Stretch JR; Behren A; Kefford RF; Hersey P; Long GV; Cebon J; Shackleton M; Spillane AJ; Saw RPM; López-Bigas N; Pearson JV; Thompson JF; Scolyer RA; Mann GJ
    Nature; 2017 May; 545(7653):175-180. PubMed ID: 28467829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational profiling of acral melanomas in Korean populations.
    Shim JH; Shin HT; Park J; Park JH; Lee JH; Yang JM; Kim DH; Jang KT; Lee DY
    Exp Dermatol; 2017 Oct; 26(10):883-888. PubMed ID: 28191690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition.
    Turajlic S; Furney SJ; Stamp G; Rana S; Ricken G; Oduko Y; Saturno G; Springer C; Hayes A; Gore M; Larkin J; Marais R
    Ann Oncol; 2014 May; 25(5):959-67. PubMed ID: 24504448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies.
    Saldanha G; Potter L; Daforno P; Pringle JH
    Clin Cancer Res; 2006 Aug; 12(15):4499-505. PubMed ID: 16899595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.
    Gui J; Guo Z; Wu D
    J Transl Med; 2022 Aug; 20(1):367. PubMed ID: 35974375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients.
    Dika E; Veronesi G; Altimari A; Riefolo M; Ravaioli GM; Piraccini BM; Lambertini M; Campione E; Gruppioni E; Fiorentino M; Melotti B; Ferracin M; Patrizi A
    Am J Clin Pathol; 2020 Apr; 153(5):664-671. PubMed ID: 32017841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
    Livingstone E; Zaremba A; Horn S; Ugurel S; Casalini B; Schlaak M; Hassel JC; Herbst R; Utikal JS; Weide B; Gutzmer R; Meier F; Koelsche C; Hadaschik E; Sucker A; Reis H; Merkelbach-Bruse S; Siewert M; Sahm F; von Deimling A; Cosgarea I; Zimmer L; Schadendorf D; Schilling B; Griewank KG
    Br J Dermatol; 2020 Nov; 183(5):928-939. PubMed ID: 32064597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.